INDVNasdaq United Kingdom
Market cap
$4.844 B
$38.82 +0.39%
Close of 7 Aug 2026
Revenue
$1.24B
#1404 by revenue
Earnings
$210.0M
#984 by earnings
Shares outstanding
118,013,649
Latest filing cover page
P/E ratio
23.1
Cap ÷ net income
Where these numbers come from
Share counts and financials for Indivior Pharmaceuticals are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.